Concepedia
Statistics
Publications
12
Citations
842
H-Index
11
Active since
1995
Affiliations
Pfizer (United States)(Current)
West Virginia University
University of Vermont
University of Arizona
National University Hospital of Iceland
Mikael Franzon is an author at Pfizer (United States) specializing in pharmacology, public health, and pharmacotherapy.
Publications per year
1995–2017
Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial
Nina Schneider, Richard Olmstead, Freny Vaghaiwalla Mody et al. · Addiction · 2003 · 124 citations
Public Health, Pharmacology, Pharmacotherapy +13
Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial
Nina Schneider, Richard Olmstead, Fredrik Nilsson et al. · Addiction · 1996 · 122 citations
Public Health, Pharmacology, Pharmacotherapy +11
Nina Schneider, Richard Olmstead, Fredrik Nilsson et al. · Addiction · 1996 · 105 citations
Nina Schneider, Richard Olmstead, Freny Vaghaiwalla Mody et al. · Addiction · 1995 · 102 citations
A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation
Thórarinn Blöndal, Mikael Franzon, Åke Westin · European Respiratory Journal · 1997 · 78 citations · Full text
Public Health, Pharmacology, Pharmacotherapy +17
1–5 of 12